With over 100 early and managed access, compassionate use, and named patient programmes running across the globe, the Operationalise: Early Access Programmes Summit Europe has been carefully created alongside experienced EAP leaders to address the operational obstacles hindering EAP progression in Europe.

Immerse yourself in three days of interactive sessions and discuss your peers’ approaches to involving the patient voice, engaging different stakeholders, planning considerations for a successful EAP and more.

With a specific focus on real-world case studies and practical applications, join us to gain a greater understanding and clarity of the end-to-end management of running an early access programme in Europe.

With a speaker faculty of over 23 industry experts from companies such as Merck Kgaa, Janssen, CSL Behring, EURORDIS, Novartis and more, join over 30 attending organisations to help us bring treatments and therapies to patients in Europe, faster.

Europe currently has over 100 early and managed access, compassionate use, and named patient programmes running across the continent. However, the multi-layered regulatory frameworks that require both EMA and country-specific legislation mean that getting pre-approved drugs to European patients is fraught with operational challenges.  

On the back of several years of successfully running the US Operationalize: Expanded Access Programs Summit, we are extremely excited to bring you the European version this October!  

By uniting Europe’s leading Early Access Programme thinkers, this exclusive platform will clarify the complex issues through end-to-end Named Patient and Compassionate Use programme operationalisation. Through open discussion, sharing best-practice case studies, and removing hypotheticals, this meeting will provide an unrivalled opportunity to solve your challenges across the entire timeline such as navigating European regulations, product labelling requirements and closing an early access programme.  

Whether you’re a veteran at managing early access programmes and are looking to expand your geo, or a new entrant to the field, you’ll leave this conference with the practical lessons and essential connections needed to supercharge your European early access programme across 2022 and beyond.  

---